Given its beneficial effects, erythropoietin is produced by recombinant deoxyribonucleic acid (DNA) technology, and this recombinant human erythropoietin (rhEPO) and its newer analogues [2] are now therapeutically used for the treatment of anemia. The gene discussed is EPO; the disease is anemia (phenotype).